from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0574c/-

LFCtreatmentdescriptionclass of inhibitor

-0.920

Amikacinug/mL Amikacintranslation

0.099

Cap5-10ug/mL Capreomycintranslation

0.783

Rox10-50 ug/mL Roxithromycintranslation

-0.550

SM2-5 ug/mL Streptomycintranslation

-0.712

Tet5-10 ug/mL Tetracyclinetranslation

-2.042

Rif0.2-5ug/mL Rifampicintranscription

-0.608

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.063

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.018

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.524

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.000

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.101

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.010

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.219

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.575

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.286

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.960

Nigericin50 uM Nigericinrespiration

-0.551

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

-0.139

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.098

menadione6-10 ug/mL Menadionerespiration

0.860

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.198

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.080

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.215

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.814

NRP_1Non-replicating persistence stage 1dosRassociated

0.026

Amp0.2mg/mL AmpicillincellWall

0.468

Cephalexin20-100 ug/mL CephalexincellWall

0.167

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.140

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.047

EMB10-20 ug/mL EthambutolcellWall

-0.202

Eta12-40 ug/mL EthionamidecellWall

0.400

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.561

TLM0.1-0.2 mg/mL ThiolactomycincellWall

2.284

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.331

BZA0.12 mg/mL BenzamidearomaticAmides

0.262

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.700

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.082

H2O24 mM hydrogen peroxideDNAdamaging

0.775

Levo10 ug/mL LevofloxacinDNAdamaging

-0.011

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.270

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.420

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.632

UVUV-irradiationDNAdamaging

0.459

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.424

Antimycin12.5-50 ug/mL Antimycin A?

0.704

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.070

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.148

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.586

PA8240.2-2 ug/mL PA-824?

0.043

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.381

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.253

Verapamil50 uM Verapamil?

0.216

mercaptoethanol2 mM 2-Mercaptoethanol?

1.400

methoxatin10-20 ug/mL Methoxatin?